A new urine test developed by researchers at the University of Michigan could offer a less invasive and more affordable alternative to traditional prostate cancer screenings. The test, which analyzes specific genetic markers, shows promise in detecting high-risk cancers and reducing unnecessary procedures like biopsies. Read the full article to discover how this development could change how prostate cancer is diagnosed and monitored, potentially improving patient comfort and healthcare costs.
